Fig. 1. Study flow chart. Group A: intensifying oral hypoglycemic agents (OHAs; sulfonylurea+metformin dose titration or fixed-dose combination added to.

Slides:

Advertisements

Similar presentations

Pharmacotherapy Oral Hypoglycemic Agents (OHA) Antihyperglycemic agents Used only in type 2 diabetes, with diet and exercise CDA Clinical Practice Guidelines.

Advertisements

The efficacy of ‘Basal supported Oral Therapy ’ with ‘Sitagliptin’ in Japanese type 2 diabetes patients: Yoshihiko Suzuki HDC Atlas Clinic,

Alice Y.Y. Cheng, MD FRCPC Peter Lin, MD CCFP

Insulin Diabetes Outreach (June 2011). 2 Insulin Learning outcomes >Understand the difference between insulin therapy in type 1 diabetes as compared to.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Insulin therapy.

Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.

Insulin Initiation and Titration for Family Physicians: Case Study #2: Andy Alice Y.Y. Cheng, MD FRCPC Peter Lin, MD CCFP.

Patient-directed titration to achieve glycaemic goals in type 2 diabetes using once-daily basal insulin: results of the TITRATE randomized controlled trial.

Endocrine and Metabolic Disorders Lectures 8 I.Kuziv, MD, PhD.

Epidemiology and Diagnosis A Practical Guide to Therapy Monotherapy Combination Therapy Add ons.

An initiative of South Asian Federation of Endocrine Societies (SAFES)

Insulin Elixir of life Dr. Sergio Diez Alvarez Staff Specialist Physician.

Adult SQ Insulin Advisor Be on the look-out for VUMC’s new subcutaneous adult insulin advisor Orderable in WIZ/HEO. Physician Driven, unlike the Insulin.

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine A 24-Week,

What's New in Basal Insulin for Diabetes

Small concise points on Insulin

Jill Little Diabetes Specialist Nurse

Fig. 2. Change in (A) glycosylated hemoglobin (HbA1c) and (B) fasting plasma glucose (FPG). Group A: oral hypoglycemic agents (OHAs; sulfonylurea+metformin.

Copyright © 2015 by the American Osteopathic Association.

Management of diabetes mellitus in hospitalized patients

Copyright © 2005 American Medical Association. All rights reserved.

From: United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients.

Matthew P. Gilbert, DO, MPH, Richard E. Pratley, MD

Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment Ippei Kanazawa, Ken-ichiro Tanaka, Masakazu.

Interventions for Clients with Diabetes Mellitus

Insulins in primary care setting

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Applying Data to Practice

Jill Little Diabetes Specialist Nurse

New Patient-Friendly Options for Managing Insulin Dosing

Modern Strategies for Basal Insulin Use in T2D

Continuous Subcutaneous Insulin Infusion (CSII) [Insulin Pump]

Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.

Insulin Intensification Strategies in Later-Stage Type 2 Diabetes Mellitus.

Working as a Team for Improved Patient Outcomes in Type 2 Diabetes

What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?

Innovative Insulin Combinations: A New strategy for the Person With T2DM.

Sequential insulin strategies in type 2 diabetes.

GLP-1 Receptor Agonists: How Early Is Appropriate?

Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?

Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53

Integrated Diabetes Care: How Can We Make the Best Use of New Technology?

Insulin Use in Primary Care: Practice Challenges

Treatment Pathway for Adults with Type 1 Diabetes

Injectable Options as Add-Ons to Basal Insulin: Targeting PPG in Type 2 Diabetes Patients.

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Novel Approaches to T1D Management

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.

Approach to starting and adjusting insulin in type 2 diabetes.

Modern strategies for management of glycaemia in type 1 diabetes

Patient flow chart: the final prospective study population consisted of 521 individuals, 113 on basal insulin and 408 on OADs. *Plausibility: height (130–230 cm),

Respondents’ perceptions on (A) the potential of IDegLira compared with basal-bolus therapy to improve patient motivation to reach their target blood glucose.

Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.

(A) Correlation between change in HbA1c and change in weight from baseline to week 24 in the liraglutide group. (A) Correlation between change in HbA1c.

Kaplan-Meier plot of incident CVD according to the treatment group over a 4-year period following intensification of diabetes therapy. Kaplan-Meier plot.

Established Type 1 Diabetes Mellitus

Emerging Combination Injectable Therapy A New Era in Diabetes Care

INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.

Fig. 3. (A) Least-squares (LS) mean difference in glycosylated hemoglobin (HbA1c) from baseline, and (B) LS mean difference in HbA1c from baseline over.

Fig. 2. Proinflammatory response of macrophages may exacerbate mitochondrial dysfunction in adipocytes. In addition to the primary mitochondrial dysfunction.

Fig. 3. Comparison of our hypothesis and “adipose tissue hypoxia” theory. The hypothesis of “adipose tissue hypoxia” explains that hypoxia occurs in enlarged.

ATL-801 treatment increases insulin sensitivity in KKAY mice.

Fig. 2. Changes in glycosylated hemoglobin (HbA1c) levels

Patient flowchart of recruitment and treatment failure and success with glyburide vs. metformin. Patient flowchart of recruitment and treatment failure.

Fixed-Ratio Combination Therapy in T2DM

Insulin Delivery Systems Atlanta Diabetes Associates

Fig. 1. Antihyperglycemic therapy algorithm for adult patients with type 2 diabetes mellitus (T2DM). The algorithm stratifies the choice of medications.

Fresh perspectives ON BASAL Insulins in diabetes care

Presentation transcript:

Fig. 1. Study flow chart. Group A: intensifying oral hypoglycemic agents (OHAs; sulfonylurea+metformin dose titration or fixed-dose combination added to other OHAs). Group B: basal insulin alone or added to OHA mono/combination therapy. Group C: basal bolus, premixed insulin, and continuous subcutaneous insulin infusion alone or added to OHA mono/combination therapy. HbA1c, glycosylated hemoglobin. Fig. 1. Study flow chart. Group A: intensifying oral hypoglycemic agents (OHAs; sulfonylurea+metformin dose titration or fixed- dose combination added to other OHAs). Group B: basal insulin alone or added to OHA mono/combination therapy. Group C: basal bolus, premixed insulin, and continuous subcutaneous insulin infusion alone or added to OHA mono/combination… Diabetes Metab J. 2017 Jun;41(3):170-178. https://doi.org/10.4093/dmj.2017.41.3.170